Dallas Cosmetic Medicine Surgery Meeting

Dallas Cosmetic Medicine & Surgery Meeting

March 10-11, 2022

This activity is jointly provided by Medical Education Resources and Dallas Cosmetic Surgery and Rhinoplasty Meetings.

This activity is supported by educational grants and/or in-kind product donations from:

Education Grants Allergan, Inc.

Endo Aesthetics Evolus Galderma Laboratories, L.P.

Merz Aesthetics

In Kind Product

Botox , Juvederm Ultra XC, Juvederm Ultra Plus XC, Juvederm Voluma XC, Juvederm Voluma TSK Cannula and needle kits, Juvederm Volbella, Juvederm Vollure XC, Kybella Skin marking grid QWO

Jeuveau

Dysport?, Restylane? Lyft, Restylane Kysse,Restylane? Refyne, Restylane? Defyne, Restylane?, Restlylane Contour, Sculptra Aesthetic Radiesse? (+) with integral 0.3% Lidocaine Radiesse? 1.5cc syringe (without integral Lidocaine) Xeomin incobotulinumtoxinA? Cosmetic 100U

Target Audience Cosmetic Symposium - Plastic Surgeons, Facial Plastic Surgeons, Otolaryngologists, Oculoplastic Surgeons, Dermatologists, Residents, Non-Physician Providers (Registered Nurses, Physician Assistants, Nurse Practitioners and Aestheticians) working in the office of a Board-Certified physician in the above specialties

Statement of Need To teach physicians and residents how to achieve safe and reproducible aesthetic results and highlight the latest techniques and advances in cosmetic surgery including face, breast and body contouring procedures. Attendees will become familiar with the latest techniques and advances in cosmetic surgery. The focus will be on controversies and advances in facial, breast and body contouring procedures including the use of fat for augmenting the face, breast and buttock. A live demonstration of the use of injectables, including new products on the market, will allow for a broad overview of products, facial analysis, and techniques. A cadaver course will be available to highlight the surgical techniques described.

Learning Outcome To update training as necessary to learn how to implement safe practices into new and emerging techniques and technologies.

Educational Objectives: After completing this activity, the participant should be better able to:

Describe advanced techniques utilizing Botulinum Toxin Type A and soft tissue fillers for facial enhancement Integrate new implant options for breast augmentation and breast shaping using new breast lift techniques Discuss the use of fat grafting to enhance the face, breast and buttock Apply a "hands on" tool to practice the techniques discussed in a cadaver model Identify new technology and patient safety in lasers, IPL, vaginal rejuvenation, noninvasive fat removal, skin

tightening, cellulite, dermal fillers and advances in skin care. Identify and assess current and emerging therapies and their role in successful patients consultations Prepare combination treatments for improved patient satisfaction Identify

 Distinguish appropriate practice management techniques for a successful medical practice and improved patient-clinician communication.

Discuss treatment options within a realistic framework of potential outcomes, and patient expectations

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Meeting Designs. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Medical Education Resources designates this live activity for a maximum of 18 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. American Nurses Credentialing Center (ANCC) Credit Designation Medical Education Resources designates this live activity for a maximum of 18 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity. American Academy of Nurse Practitioners (ANNP) Credit Designation The American Academy of Nurse Practitioners (AANP) Certification Board recognizes and accepts continuing education (CE) 18 contact hours from activities approved by AMA, ACCME, ANCC, AANP. Physician Assistant Credit Designation Medical Education Resources has been authorized by the American Academy of Pas (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 18 AAPA Category 1 CME credits. Pas should only claim credit commensurate with the extent of their participation.

Disclosure of Conflicts of Interest General Session Medical Education Resources insures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:

Name of Faculty William Adams, Jr, MD Jamil Ahmad, MD

Christopher Chia, MD Suneel Chilukuri, MD

Reported Financial Relationship

Ownership Interest/Shareholder: Tepha Consulting Fees: Allergan, Mentor, InMode, Venus Concepts Royalty/Patent Holder: Thieme Ownership Interest/Shareholder: InMode Corporation

Grants/Research Support: Allergan, BTL, InMode, Prollenium, Sciton

Consulting Fees: Aerolase, AMP, Allergan, BTL, Clarity, Crown, Eclipse, Evolus, Galderma, InMode, Merz, Prollenium, PCA, Revance, Sceintis, Sciton, Skin Medica, ZO Skin Speakers' Bureau: Aerolase, AMP, Allergan, BTL, Clarity, Crown, Eclipse, Evolus, Galderma, InMode, Merz, Prollenium, PCA, Revance, Sceintis, Sciton, Skin Medica, ZO Skin

Daniel Del Vecchio, MD Dino Elyassnia, MD Steven Fagien, MD Ashkan Ghavami, MD Michael Gold, MD

Elizabeth Houshmand, MD Alfredo Hoyos, MD Roy Kim, MD Mary Lupo, MD

Donald Mowlds, MD

No financial relationships to disclose No financial relationships to disclose

Consulting Fees: Allergan, AbbVie, Evolus, Merz, Revance, Alastin No financial relationships to disclose

Consulting Fees: Aerolase, AMP, Aesthetic Bio Medical, Alastin, Allergan, Almirall, Bausch Health, BrandMD, Croma, Dermaroller, Endo Aesthetics, EndyMed, , Galderma, Hugel, InMode, Leo Pharm, Lumenis, Merz, Mindera, MTF, NanoPass, Neauvia, Nutrafol, Pierre Fabre/Glytone, Revision, Prescriber's Choice, Revance, Revision Skin Care, Rohrer Aesthetic, Sciton, Sensus, Sente, Skinbetter Science, SkinCeuticals, Skin Medica, Sofwave, Soliton, Stratpharma, Suneva, Topix, Venus Concepts

Consulting Fees: Allergan, Merz No financial relationships to disclose No financial relationships to disclose Grants/Research Support: Bausch Health, Brickell, Inmode, ChemoCentryx, , Novan Molluscum, Strathspey Crown Consulting Fees: Allergan, Pulse Bioscience, Eastern College of Health Vocations LLC, Revance Therapeutics, Revision Skincare, Solta/Valeant, Theraplex, TopMD Speakers' Bureau: Allergan, Bellus, Lumenis, Merz Thraplex,Ortho Dermatologics, Revision Skincare, Solta/Valeant, Theraplex Ownership Interest/Shareholder: Cosmetic Bootcamp, LLC, Alphaeon, Evolus, TopMD Royalty/Patent Holder: Flex HD MAX ? MTF Biologics

Dallas 2020

Rod J. Rohrich, MD

David Sieber, MD James Stuzin, MD Jacob Unger, MD Jennifer Walden, MD

David Weir, NP

Grants/Research Support: Galderma, MTF Biologics, Allergan, InMode Consulting Fees: Allergan, MTF Biologics, Galderma, InMode Ownership Interest/Shareholder: Medical Seminars of Texas, LLC Royalty/Patent Holder: Thieme Publishing, Eriem Surgical Consulting Fees: Apyx Medical No financial relationships to disclose Consulting Fees: Allergan Consulting Fees: Endo Aesthetics, Dominion Aesthetics, Sciton Ownership Interest/Shareholder: InMode Aesthetics, Ideal Implant No financial relationships to disclose:

Dallas 2020

Rod J. Rohrich, MD

David Sieber, MD James Stuzin, MD Spero Theodorou, MD Jacob Unger, MD David Weir, NP James Zins, MD

Grants/Research Support: Allergan, Galderma, MTF Biologics InMode, Crown Aesthetics Clinical and Research Expert: Allergan, MTF Biologics, Galderma Ownership Interest/Shareholder: Medical Seminars of Texas, LLC Royalty/Patent Holder: Eriem Surgical, Thieme Publishing, Medical Monitor: Merz No financial relationships to disclose No financial relationships to disclose

Ownership Interest/Shareholder: InMode

Speakers' Bureau: InMode Royalty/Patent Holder: Allergan No financial relationships to disclose No financial relationships to disclose

The content managers reported the following financial relationships with commercial interests whose products or

services may be mentioned in this CME activity:

Name of Content Manager

Reported Financial Relationship

Karen S. Dennis, Meeting Designs, LLC

No financial relationships to disclose

Planners from MER

No financial relationships to disclose

Dallas 2020

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download